See All Slides - tctmd.com

Slides

Presentation TCT 2016

Complications of Structural Heart Disease Intervention

Presenter: George S. Hanzel, Mauricio G. Cohen

October 31, 2016

Presentation TCT 2016

Case #2: A TAVR Complication to Learn From

Presenter: Antonio Colombo, Jeffrey W. Moses, Augusto D. Pichard

October 31, 2016

Presentation TCT 2016

Bioresorbable Vascualr Scaffolds: The Future of PCI?

Presenter: Vinay K. Bahl, Amal Kumar Banerjee, Jamshed J. Dalal, Narenda N. Khanna, Ajay J. Kirtane, C. Venkata S. Ram, Kamal K. Sethi, Sundeep Mishra

October 31, 2016

Presentation TCT 2016

CardiAQ: Design and Clinical Trial Updates

Presenter: Michael J. Mack, Ralph Stephan von Bardeleben, Gian Paolo Ussia

October 31, 2016

Presentation TCT 2016

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No Short-Term Data Is Borderline, Procedures Are More Costly And Complex, And Long-Term Data Is Scant Best To Wait!

Presenter: Stephen G. Ellis, Corrado Tamburino, Daniel I. Simon

October 31, 2016

Presentation TCT 2016

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

Presenter: William A. Gray, Stephan Windecker, Vinod H. Thourani

October 31, 2016

Presentation TCT 2016

Importance of Calcification on PCI Techniques and Outcomes: The Costs of Atherectomy-Regret

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Philippe Généreux

October 31, 2016

Presentation TCT 2016

Early Feasibility Studies in USA: Progress Report From the FDA

Presenter: Andrew Farb, Aaron V. Kaplan, Carla M Wiese

October 31, 2016

Presentation TCT 2016

How Did I Treat This Case?

Presenter: Jun-Jack Cheng, Gary S. Mintz, Chiung Jen Wu, Chun-Chi Chen

October 31, 2016

Presentation TCT 2016

Israel Responds: How Would I Treat?

Presenter: Ariel Finkelstein, Ugo Limbruno, Haim Danenberg

October 31, 2016

Advertisement

Slides

Complications of Structural Heart Disease Intervention

Case #2: A TAVR Complication to Learn From

Bioresorbable Vascualr Scaffolds: The Future of PCI?

CardiAQ: Design and Clinical Trial Updates

The Great Absorb Debate: Is Absorb Ready To Be Used In Most Patients And Lesions? No Short-Term Data Is Borderline, Procedures Are More Costly And Complex, And Long-Term Data Is Scant Best To Wait!

Trial #6 - The Essentials ofPARTNER 2 and SAPIEN 3 - TAVR In Intermediate Risk Patients, and Improved TAVR Devices

Importance of Calcification on PCI Techniques and Outcomes: The Costs of Atherectomy-Regret

Early Feasibility Studies in USA: Progress Report From the FDA

How Did I Treat This Case?

Israel Responds: How Would I Treat?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content